The Galen™ Platform

banner

Benefits for
pathologists

  • More time to dedicate to complex cases and research
  • Less tedious, tiring and stressful

Benefits for
patients

  • Increased diagnostic accuracy
  • More objective results

Benefits for
pathology labs

  • Increased efficiency
  • Decreased turnaround time
  • Improved quality of service

Benefits for the
health system

  • Lower costs
  • Standardized procedures
  • Faster, enhanced research

CANCERS DETECTED BY THE GALEN PLATFORM

Breast > Cancer, DCIS

Prostate > Cancer, G6

Prostate > Cancer, G7 + Perineural

The Galen™ platform is a Research Use Only device in the United States and was not cleared by the FDA. Certain solutions and applications under the Galen platform are CE-Marked and approved in additional territories. Contact Ibex Medical Analytics for more information.